Cyclopentenone Prostaglandins with Dienone Structure Promote Cross-Linking of the Chemoresistance-Inducing Enzyme Glutathione Transferase P1-1

Glutathione transferase P1-1 (GSTP1-1) plays crucial roles in cancer chemoprevention and chemoresistance and is a key target for anticancer drug development. Oxidative stress or inhibitor-induced GSTP1-1 oligomerization leads to the activation of stress cascades and apoptosis in various tumor cells. Therefore, bivalent glutathione transferase (GST) inhibitors with the potential to interact with GST dimers are been sought as pharmacological and/or therapeutic agents. Here we have characterized GSTP1-1 oligomerization in response to various endogenous and exogenous agents. Ethacrynic acid, a classic GSTP1-1 inhibitor, 4-hydroxy-nonenal, hydrogen peroxide, and diamide all induced reversible GSTP1-1 oligomerization in Jurkat leukemia cells through the formation of disulphide bonds involving Cys47 and/or Cys101, as suggested by reducing and nonreducing SDS-polyacrylamide gel electrophoresis analysis of cysteine to serine mutants. Remarkably, the electrophilic prostanoid 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) induced irreversible GSTP1-1 oligomerization, specifically involving Cys101, a residue present in the human but not in the murine enzyme. 15d-PGJ2-induced GSTP1-1 cross-linking required the prostaglandin (PG) dienone structure and was associated with sustained c-Jun NH2-terminal kinase activation and induction of apoptosis. It is noteworthy that 15d-PGJ2 elicited GSTP1-1 cross-linking in vitro, a process that could be mimicked by other dienone cyclopentenone PG, such as Δ12-PGJ2, and by the bifunctional thiol reagent dibromobimane, suggesting that cyclopentenone PG may be directly involved in oligomer formation. Remarkably, Δ12-PGJ2-induced oligomeric species were clearly observed by electron microscopy showing dimensions compatible with GSTP1-1 tetramers. These results provide the first direct visualization of GSTP1-1 oligomeric species. Moreover, they offer novel strategies for the modulation of GSTP1-1 cellular functions, which could be exploited to overcome its role in cancer chemoresistance.

[1]  G. Aldini,et al.  Delta12-prostaglandin J2 as a product and ligand of human serum albumin: formation of an unusual covalent adduct at His146. , 2010, Journal of the American Chemical Society.

[2]  J. A. Murray,et al.  Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia , 2009, PloS one.

[3]  N. Kitteringham,et al.  A mechanistic investigation into the irreversible protein binding and antigenicity of p-phenylenediamine. , 2009, Chemical research in toxicology.

[4]  D. Townsend,et al.  Novel Role for Glutathione S-Transferase π , 2009, Journal of Biological Chemistry.

[5]  A. Townsend,et al.  Expression of MRP1 and GSTP1-1 modulate the acute cellular response to treatment with the chemopreventive isothiocyanate, sulforaphane. , 2008, Carcinogenesis.

[6]  Luigi Frati,et al.  Inhibition of Trail Gene Expression by Cyclopentenonic Prostaglandin 15-Deoxy-Δ12,14-Prostaglandin J2 in T Lymphocytes , 2007, Molecular Pharmacology.

[7]  R. Curi,et al.  LipoCardium: endothelium-directed cyclopentenone prostaglandin-based liposome formulation that completely reverses atherosclerotic lesions. , 2007, Atherosclerosis.

[8]  K. Tew,et al.  Redox in redux: Emergent roles for glutathione S-transferase P (GSTP) in regulation of cell signaling and S-glutathionylation. , 2007, Biochemical pharmacology.

[9]  G. Aldini,et al.  Identification of actin as a 15-deoxy-Delta12,14-prostaglandin J2 target in neuroblastoma cells: mass spectrometric, computational, and functional approaches to investigate the effect on cytoskeletal derangement. , 2007, Biochemistry.

[10]  D. Pérez-Sala,et al.  Direct evidence for the covalent modification of glutathione-S-transferase P1-1 by electrophilic prostaglandins: implications for enzyme inactivation and cell survival. , 2007, Archives of biochemistry and biophysics.

[11]  P. Cassidy,et al.  Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles. , 2006, Carcinogenesis.

[12]  T. Snape,et al.  Induction of Apoptosis in Estrogen Receptor-Negative Breast Cancer Cells by Natural and Synthetic Cyclopentenones: Role of the IκB Kinase/Nuclear Factor-κB Pathway , 2006, Molecular Pharmacology.

[13]  Y. Jiang,et al.  Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2–ASK1 signals , 2006, Oncogene.

[14]  W. Miller,et al.  Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4 , 2006, Annals of Hematology.

[15]  B. van de Water,et al.  Peptide-bond modified glutathione conjugate analogs modulate GSTpi function in GSH-conjugation, drug sensitivity and JNK signaling. , 2006, Biochemical pharmacology.

[16]  Konstantinos Stamatakis,et al.  Identification of novel protein targets for modification by 15-deoxy-Delta12,14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton. , 2005, Journal of the American Society of Nephrology : JASN.

[17]  L. Ghibelli,et al.  Proapoptotic activity of new glutathione S-transferase inhibitors. , 2005, Cancer research.

[18]  K. Stamatakis,et al.  Protein Thiol Modification by 15-deoxy-Δ12,14-Prostaglandin J2 Addition in Mesangial Cells: Role in the Inhibition of Pro-inflammatory Genes , 2004, Molecular Pharmacology.

[19]  W. Atkins,et al.  A novel antioxidant role for ligandin behavior of glutathione S-transferases: attenuation of the photodynamic effects of hypericin. , 2004, Biochemistry.

[20]  W. Fischer,et al.  Protein Disulfide Bond Formation in the Cytoplasm during Oxidative Stress* , 2004, Journal of Biological Chemistry.

[21]  A. Fisher,et al.  Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Townsend,et al.  Glutathione S-transferases (GSTs) inhibit transcriptional activation by the peroxisomal proliferator-activated receptor gamma (PPAR gamma) ligand, 15-deoxy-delta 12,14prostaglandin J2 (15-d-PGJ2). , 2004, Biochemistry.

[23]  F. Cañada,et al.  Molecular Basis for the Direct Inhibition of AP-1 DNA Binding by 15-Deoxy-Δ12,14-prostaglandin J2* , 2003, Journal of Biological Chemistry.

[24]  K. Lauber,et al.  Cyclopentenone Prostaglandins Induce Lymphocyte Apoptosis by Activating the Mitochondrial Apoptosis Pathway Independent of External Death Receptor Signaling 1 , 2003, The Journal of Immunology.

[25]  S. Cuzzocrea,et al.  2‐Cyclopenten‐1‐one and prostaglandin J2 reduce restenosis after balloon angioplasty in rats: role of NF‐κB , 2003, FEBS letters.

[26]  H. Masutani,et al.  Thioredoxin as a Molecular Target of Cyclopentenone Prostaglandins* , 2003, Journal of Biological Chemistry.

[27]  C. Gong,et al.  Glutathion S transferase pi indicates chemotherapy resistance in breast cancer. , 2003, The Journal of surgical research.

[28]  Dolores Pérez-Sala,et al.  15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit. , 2001, The Journal of biological chemistry.

[29]  A. Sinz,et al.  Mapping protein interfaces with a fluorogenic cross-linker and mass spectrometry: application to nebulin-calmodulin complexes. , 2001, Biochemistry.

[30]  G. Melino,et al.  Modulation of GST P1‐1 activity by polymerization during apoptosis , 2000, Journal of cellular biochemistry.

[31]  Y. Kawamoto,et al.  Cyclopentenone Prostaglandins as Potential Inducers of Phase II Detoxification Enzymes , 2000, The Journal of Biological Chemistry.

[32]  W Chiu,et al.  EMAN: semiautomated software for high-resolution single-particle reconstructions. , 1999, Journal of structural biology.

[33]  P. van Bladeren,et al.  Interactions of prostaglandin A2 with the glutathione-mediated biotransformation system. , 1999, Biochemical pharmacology.

[34]  M. Pincus,et al.  Regulation of JNK signaling by GSTp , 1999, The EMBO journal.

[35]  F. Cañada,et al.  Analogs of farnesylcysteine induce apoptosis in HL‐60 cells , 1998, FEBS letters.

[36]  P. van Bladeren,et al.  Interactions of alpha, beta-unsaturated aldehydes and ketones with human glutathione S-transferase P1-1. , 1997, Chemico-biological interactions.

[37]  A. Caccuri,et al.  Redox forms of human placenta glutathione transferase. , 1991, The Journal of biological chemistry.

[38]  L. Roberts,et al.  Formation of thiol conjugates of 9-deoxy-delta 9,delta 12(E)-prostaglandin D2 and delta 12(E)-prostaglandin D2. , 1990, Biochemistry.

[39]  Do-Hee Kim,et al.  15-Deoxy-delta 12, 14-prostaglandin J2 induces upregulation of multidrug resistance-associated protein 1 via Nrf2 activation in human breast cancer cells. , 2009, Annals of the New York Academy of Sciences.

[40]  W. Atkins,et al.  Bivalent inhibitors of glutathione S-transferase: the effect of spacer length on isozyme selectivity. , 2006, Bioorganic & medicinal chemistry letters.

[41]  L. Pease,et al.  In vitro recombination and mutagenesis by overlap extension PCR. , 1996, Methods in molecular biology.

[42]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.